DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,656 | -9.6% | 366 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $5,153 | -8.9% | 366 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $5,655 | -26.4% | 366 | -22.0% | 0.00% | 0.0% |
Q4 2022 | $7,687 | -23.1% | 469 | -9.6% | 0.00% | -50.0% |
Q3 2022 | $10,000 | +66.7% | 519 | +10.7% | 0.00% | +100.0% |
Q2 2022 | $6,000 | +500.0% | 469 | +230.3% | 0.00% | – |
Q1 2022 | $1,000 | -75.0% | 142 | +34.0% | 0.00% | -100.0% |
Q2 2021 | $4,000 | – | 106 | +1414.3% | 0.00% | – |
Q1 2021 | $0 | – | 7 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 7 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 7 | 0.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 7 | -70.8% | 0.00% | – |
Q1 2020 | $1,000 | – | 24 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |